Letter: Lactobacillus rhamnosus GG offers no benefit over placebo in children with acute gastroenteritis. Authors' reply

Affiliations

¹ The Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland.
² Sackler Faculty of Medicine, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center, Tel-Aviv University, Tel-Aviv, Israel.

Comment

Hania Szajewska et al. Aliment Pharmacol Ther. 2019 Sep.

. 2019 Sep;50(5):622-623.

doi: 10.1111/apt.15431.

¹ The Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland.
² Sackler Faculty of Medicine, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center, Tel-Aviv University, Tel-Aviv, Israel.

No abstract available

Comment on

Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children - a 2019 update.
Szajewska H, Kołodziej M, Gieruszczak-Białek D, Skórka A, Ruszczyński M, Shamir R. Szajewska H, et al. Aliment Pharmacol Ther. 2019 Jun;49(11):1376-1384. doi: 10.1111/apt.15267. Epub 2019 Apr 25. Aliment Pharmacol Ther. 2019. PMID: 31025399
Letter: Lactobacillus rhamnosus GG offers no benefit over placebo in children with acute gastroenteritis.
Schnadower D, Tarr PI, Freedman SB. Schnadower D, et al. Aliment Pharmacol Ther. 2019 Sep;50(5):620-622. doi: 10.1111/apt.15418. Aliment Pharmacol Ther. 2019. PMID: 31414542 No abstract available.